CA Patent

CA2744458A1 — Novel processes and pure polymorphs

Assigned to Generics UK Ltd · Expires 2010-06-03 · 16y expired

What this patent protects

The present invention relates to crystalline forms of the active pharmaceutical ingredient vorinostat, processes for their preparation and their use in pharmaceutical compositions.

USPTO Abstract

The present invention relates to crystalline forms of the active pharmaceutical ingredient vorinostat, processes for their preparation and their use in pharmaceutical compositions.

Drugs covered by this patent

Patent Metadata

Patent number
CA2744458A1
Jurisdiction
CA
Classification
—
Expires
2010-06-03
Drug substance claim
No
Drug product claim
No
Assignee
Generics UK Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.